Literature DB >> 3891326

The HBV HBX gene expressed in E. coli is recognised by sera from hepatitis patients.

A Kay, E Mandart, C Trepo, F Galibert.   

Abstract

We have cloned the X gene (HBx) and the HBc antigen (HBc Ag) gene of human hepatitis B virus (HBV) in Escherichia coli as fusion products with beta-galactosidase. Both HBV genes are expressed in E. coli strain CSR 603. Expression is detected by u.v. irradiation of the bacteria, metabolic labelling and electrophoresis of the labelled extracts on SDS-polyacrylamide gels. The HBc Ag protein produced in bacteria can be recognised by anti-HBc sera and peptides derived from the protein are also recognised by anti-HBe sera. The HBx protein is recognised by some, but not all, sera which are anti-HBe positive. HBx Ag is also recognised by a woodchuck antibody similar to anti-HBe (anti-WHe). These results constitute the first proof that the open reading frame X is a true viral gene and is expressed during HBV (and WHV) infection and that an HBx/anti-HBx system, which may have important biological implications, can exist in parallel with the classic HBe/anti-HBe system.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3891326      PMCID: PMC554338          DOI: 10.1002/j.1460-2075.1985.tb03774.x

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  30 in total

1.  A rapid alkaline extraction procedure for screening recombinant plasmid DNA.

Authors:  H C Birnboim; J Doly
Journal:  Nucleic Acids Res       Date:  1979-11-24       Impact factor: 16.971

2.  New specificities in Australia antigen positive sera distinct from the Le Bouvier determinants.

Authors:  L O Magnius; J A Espmark
Journal:  J Immunol       Date:  1972-11       Impact factor: 5.422

3.  A film detection method for tritium-labelled proteins and nucleic acids in polyacrylamide gels.

Authors:  W M Bonner; R A Laskey
Journal:  Eur J Biochem       Date:  1974-07-01

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

5.  Antigenic conversion from HBcAg to HBeAg by degradation of hepatitis B core particles.

Authors:  H Ohori; M Yamaki; S Onodera; E Yamada; N Ishida
Journal:  Intervirology       Date:  1980       Impact factor: 1.763

6.  Heterogeneity and thermolability of 'e'.

Authors:  A Williams; G Le Bouvier
Journal:  Bibl Haematol       Date:  1976

7.  Large surface proteins of hepatitis B virus containing the pre-s sequence.

Authors:  K H Heermann; U Goldmann; W Schwartz; T Seyffarth; H Baumgarten; W H Gerlich
Journal:  J Virol       Date:  1984-11       Impact factor: 5.103

8.  Localization on the viral genome and nucleotide sequence of the gene coding for the two major polypeptides of the hepatitis B surface antigen (HBs Ag).

Authors:  P Charnay; E Mandart; A Hampe; F Fitoussi; P Tiollais; F Galibert
Journal:  Nucleic Acids Res       Date:  1979-09-25       Impact factor: 16.971

9.  Bacteriophage lambda and plasmid vectors, allowing fusion of cloned genes in each of the three translational phases.

Authors:  P Charnay; M Perricaudet; F Galibert; P Tiollais
Journal:  Nucleic Acids Res       Date:  1978-12       Impact factor: 16.971

10.  HBeAg and anti-HBe detection by radioimmunoassay: correlation with vertical transmission of hepatitis B virus in Taiwan.

Authors:  C E Stevens; R A Neurath; R P Beasley; W Szmuness
Journal:  J Med Virol       Date:  1979       Impact factor: 2.327

View more
  23 in total

1.  Different regions of hepatitis B virus X protein are required for enhancement of bZip-mediated transactivation versus transrepression.

Authors:  S Barnabas; O M Andrisani
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

2.  Alternate translation initiation on hepatitis B virus X mRNA produces multiple polypeptides that differentially transactivate class II and III promoters.

Authors:  L Kwee; R Lucito; B Aufiero; R J Schneider
Journal:  J Virol       Date:  1992-07       Impact factor: 5.103

Review 3.  The enigmatic X gene of hepatitis B virus.

Authors:  Michael J Bouchard; Robert J Schneider
Journal:  J Virol       Date:  2004-12       Impact factor: 5.103

4.  XAP2, a novel hepatitis B virus X-associated protein that inhibits X transactivation.

Authors:  N Kuzhandaivelu; Y S Cong; C Inouye; W M Yang; E Seto
Journal:  Nucleic Acids Res       Date:  1996-12-01       Impact factor: 16.971

5.  Antibodies to pre-S and X determinants arise during natural infection with ground squirrel hepatitis virus.

Authors:  D H Persing; H E Varmus; D Ganem
Journal:  J Virol       Date:  1986-10       Impact factor: 5.103

6.  X-region-specific transcript in mammalian hepatitis B virus-infected liver.

Authors:  S Kaneko; R H Miller
Journal:  J Virol       Date:  1988-11       Impact factor: 5.103

7.  Antibodies to hepatitis B virus x-protein in sera of patients with acute and chronic active hepatitis.

Authors:  R Abraham; H W Doerr; W Braun; M Stemler; H Will; G Hess; C H Schröder
Journal:  Med Microbiol Immunol       Date:  1989       Impact factor: 3.402

8.  Transcriptional activation of homologous and heterologous genes by the hepatitis B virus X gene product in cells permissive for viral replication.

Authors:  R Colgrove; G Simon; D Ganem
Journal:  J Virol       Date:  1989-09       Impact factor: 5.103

9.  Detection of the hepatitis B virus X protein (HBx) antigen and anti-HBx antibodies in cases of human hepatocellular carcinoma.

Authors:  Guang-Yuh Hwang; Chuang-Yu Lin; Li-Mei Huang; Yan-Hsiung Wang; Jing-Chyi Wang; Ching-Ting Hsu; Sheng-Shun Yang; Cheng-Chung Wu
Journal:  J Clin Microbiol       Date:  2003-12       Impact factor: 5.948

10.  Hepatitis B virus X protein transactivates the long terminal repeats of human immunodeficiency virus types 1 and 2.

Authors:  M Levrero; C Balsano; G Natoli; M L Avantaggiati; E Elfassi
Journal:  J Virol       Date:  1990-06       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.